Skip Navigation

Nephrology Dialysis Transplantation 2006 21(Supplement 2):ii8-ii11; doi:10.1093/ndt/gfl184
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fabbrini, P.
Right arrow Articles by van den Born, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fabbrini, P.
Right arrow Articles by van den Born, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Peritoneal exposure model in the rat as a tool to unravel bio(in)compatibility of PDF

Paolo Fabbrini1, Mohammad Zareie1, Piet M. ter Wee2, Eelco D. Keuning1, Robert H. J. Beelen1 and Jacob van den Born1

1 Department of Molecular Cell Biology & Immunology and 2 Department of Nephrology, VU University Medical Center, Amsterdam, The Netherlands

Correspondence and offprint requests to: J. van den Born, PhD, VU Medical Center, De Boeleaan 1117, 1081 HV Amsterdam, The Netherlands. Email: j.vandenborn{at}vumc.nl

Patients treated with peritoneal dialysis (PD) are at risk for development of ultrafiltration failure and peritonitis. The relative unphysiologic composition of the currently used peritoneal dialysis fluids (PDF) is a major cause for the development of morphologic changes of the peritoneal membrane such as fibrosis and new vessel formation, ultimately resulting in ultrafiltration failure. In recent years, a major research focus has become the development of new and improved PDF. Typically, the first phase of biocompatibility testing of new PDF involves in vitro testing, using cell culture systems such as primary mesothelial cells or peritoneal macrophages. In vivo studies using animal models permit the analysis of biocompatibility under conditions that allow for cell-to-cell interactions and dynamic changes in solution composition that more closely mimic the clinical situation. In this paper, we will review the applicability of a peritoneal exposure model in the rat to study PDF biocompatibility-related issues.

Keywords: peritoneal; rat; dialysis; biocompatibility; fibrosis; angiogenesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.